Ildefonso Rodriguez-Leyva

researcher

Born 2000-01-01

Ildefonso Rodriguez-Leyva is …
instance of (P31):
humanQ5

External links are
P213ISNI0000000078023991
P244Library of Congress authority IDno2010061435
P2798Loop ID429323
P496ORCID iD0000-0002-3316-1471
P1053ResearcherIDG-8398-2018
P2038ResearchGate profile IDIldefonso_Rodriguez-Leyva
P1153Scopus author ID16043882200
P214VIAF ID120549993
P10832WorldCat Entities IDE39PBJjmT8QPJ6tD9DgxGqFR8C

P27country of citizenshipMexicoQ96
P69educated atAutonomous University of San Luis PotosíQ7894242
P108employerMassachusetts General HospitalQ126412
Autonomous University of San Luis PotosíQ7894242
Hospital Central Dr. Ignacio Morones PrietoQ29054809
P735given nameIldefonsoQ3796357
IldefonsoQ3796357
P106occupationresearcherQ1650915
P551residenceSan Luis PotosíQ78980
P21sex or gendermaleQ6581097
P2031work period (start)1987-01-01

Reverse relations

author (P50)
Q37335864A common haplotype within the PON1 promoter region is associated with sporadic ALS.
Q92846521A novel disposable sensor for measure intra-abdominal pressure
Q33963019Effect of vigabatrin on the pharmacokinetics of carbamazepine
Q33661884Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial
Q53742122EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process.
Q28143122Exposure to arsenic and lead and neuropsychological development in Mexican children
Q90177099Extended-release vinpocetine: a possible adjuvant treatment for focal onset epileptic seizures
Q47943598Fluorescence background removal method for biological Raman spectroscopy based on empirical mode decomposition.
Q100439373Hemichorea-Hemiballism: An Uncommon Presentation of Central Nervous System Tuberculosis
Q60912571Late onset adrenoleukodystrophy: A review related clinical case report
Q93175431Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study
Q46717008New VAPB deletion variant and exclusion of VAPB mutations in familial ALS.
Q41312269Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts.
Q34155982Paraoxonase gene mutations in amyotrophic lateral sclerosis
Q36639646Parkinson disease and progressive supranuclear palsy: protein expression in skin.
Q90192013Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression
Q89955989Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy
Q30442798Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate
Q28943310Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis
Q48303426Skin biomarkers for neurodegenerative disease: a future perspective.
Q42683308Tau Protein in Oral Mucosa and Cognitive State: A Cross-sectional Study
Q59576415The Presence of Alpha-Synuclein in Skin from Melanoma and Patients with Parkinson's Disease
Q50104927The resurgence of meningeal tuberculosis in Mexico: A social phenomenon.
Q46131276Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study.
Q34286993α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism

Search more.